Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774254 · ClinicalTrials.gov registry record · NA
Reactions to Disease Risk Information
A NA study, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT00774254 is a NA study that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 132 participants.
The verdict
NCT00774254, a NA study, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
This study is part of an effort to learn about interactions between doctors and patients. The study will use virtual reality technology to examine how patients and doctors interact when they discuss disease risks. Men and women between the ages of 25 and 40 who have access to the Internet and were born and raised in the United States may be eligible for this study. Participants will be recruited from the Washington D.C. area. Participants undergo the following procedures: * Complete an online questionnaire about their health-related background, family health history, cancer risk perceptions, and demographic information (e.g., age, marital status, education, etc.). * Participate in activities in a virtual reality environment in which they interact with a virtual doctor in a virtual clinical scenario. For this experiment, participants wear a head-mounted display that allows them to see the virtual world images. * Fill out a second questionnaire after completing the virtual reality activities. This questionnaire includes information on the participants virtual reality experience, the information provided in the experience, and questions about themselves and their background.
Interventions
- BEHAVIORAL A
- BEHAVIORAL B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2009-06-16 |
| Est. Completion | 2010-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00774254
The ClinicalTrials.gov registry entry for NCT00774254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which A is the first listed.
NCT00774254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00774254 about?
NCT00774254 is a clinical study titled "Reactions to Disease Risk Information". This study is part of an effort to learn about interactions between doctors and patients. The study will use virtual reality technology to examine how patients and doctors interact when they discuss disease risks. Men and women between the ages of 25 and 40 who have access to the Internet and were ...
What is the current status of trial NCT00774254?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2009-06-16. Estimated completion is 2010-09-30.
What interventions are being tested in trial NCT00774254?
The interventions under investigation include: A (BEHAVIORAL), B (BEHAVIORAL).
Who is sponsoring clinical trial NCT00774254?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.